Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check3 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study details, indicating restricted access to the page.SummaryDifference19%

- Check10 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, indicating a page update rather than substantive changes to the study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a newer build of the page/template. This is a software/documentation update rather than a change to the study content or results.SummaryDifference0.0%

- Check31 days agoChange DetectedAdded an NIH funding reference '2018 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers, indicating U.S. NIH support for the study. This clarifies the study's funding source and provenance.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor version update to the page assets or documentation.SummaryDifference0.0%

- Check60 days agoChange DetectedThe site shows a revision upgrade from v3.6.3 to v3.6.4, indicating a minor release. It does not modify the study details or other user-facing content on the page.SummaryDifference0.0%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.